NDT Advance Access published online on May 5, 2004
Nephrology Dialysis Transplantation, doi:10.1093/ndt/gfh280
© 2004 by European Renal Association - European Dialysis and Transplant Association
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 University of Missouri, Kansas City, School of Pharmacy, Kansas City, MI, USA; Dialysis Clinic, Inc., Kansas City, MI, USA
* To whom correspondence should be addressed. E-mail: manleyh{at}umkc.edu.
Background. End-stage renal disease (ESRD) patients are prescribed numerous medications. The United States Renal Data System (USRDS) reported on medication prescribing patterns in 1998. Since then, several new medications, treatment guidelines and recommendations have been introduced. The objective was to analyse and compare haemodialysis (HD) patient medication prescribing patterns between the Dialysis Clinic, Inc. (DCI) database and the USRDS report. Methods. Point-prevalent (01/01/03) medication use data from the DCI national database was obtained. Data collected included patient demographics, reason for and duration of ESRD, and medication listed on profile. All medications were classified similar to the USRDS and by where taken (clinic vs home). Medication prescribing patterns were compared between DCI and USRDS databases. Comparisons between age groups (<!!!!65 and Results. There were 128 477 medication orders categorized in 10 474 patients. DCI patient demographics were similar to present USRDS patients except for fewer Hispanics (P<0.001). Patients were prescribed 12.3±5.0 (median 12) different medications (2.6±1.4 clinic medications and 10.0±4.5 home medications). This is higher than reported by USRDS (median 9 medications). Patient age did not influence number of medications used (P = 0.54). DM patients are prescribed more medications than non-DM (13.3±5.0 DM vs 11.6±4.8 non-DM; P<0.00001). All medication class prescribing patterns were markedly different. Conclusion. The data suggest that medication prescribing patterns in HD patients have changed. The audit identified appropriate and questionable prescribing patterns. Various prescribing patterns identified areas for improvement in care (e.g. increased use of aspirin, beta-blockers and hyperlipidaemia medications) and areas requiring further investigation (e.g. high use of anti-acid, benzodiazepine and non-aluminum/non-calcium phosphate-binding medications).
Accepted March 24, 2004
Original Article
Medication prescribing patterns in ambulatory haemodialysis patients: comparisons of USRDS to a large not-for-profit dialysis provider
2 University of Missouri, Kansas City, School of Pharmacy, Kansas City, MI, USA
3 Dialysis Clinic, Inc., Kansas City, MI, USA
4 Dialysis Clinic, Inc., Kansas City, MI, USA; Kidney Associates of Kansas City, Kansas City, MI, USA
Abstract 
65 years) and diabetic status [diabetes mellitus (DM) vs non-DM] were made.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  K. E. Chan, J. M. Lazarus, R. Thadhani, and R. M. Hakim Warfarin Use Associates with Increased Risk for Stroke in Hemodialysis Patients with Atrial Fibrillation J. Am. Soc. Nephrol., October 1, 2009; 20(10): 2223 - 2233. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Hirsch The internist's role in treating hypertension in hemodialysis patients QJM, July 1, 2009; 102(7): 501 - 507. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-W. Chiu, I. Teitelbaum, M. Misra, E. M. de Leon, T. Adzize, and R. Mehrotra Pill Burden, Adherence, Hyperphosphatemia, and Quality of Life in Maintenance Dialysis Patients Clin. J. Am. Soc. Nephrol., June 1, 2009; 4(6): 1089 - 1096. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Mehrotra, K. J. Martin, S. Fishbane, S. M. Sprague, S. Zeig, M. Anger, and for the Fosrenol Overview Research Evaluation Stud Higher Strength Lanthanum Carbonate Provides Serum Phosphorus Control With a Low Tablet Burden and Is Preferred by Patients and Physicians: A Multicenter Study Clin. J. Am. Soc. Nephrol., September 1, 2008; 3(5): 1437 - 1445. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. A. Block, S. Zeig, J. Sugihara, G. M. Chertow, E. M. Chi, S. A. Turner, D. A. Bushinsky, and for the TARGET Investigators Combined therapy with cinacalcet and low doses of vitamin D sterols in patients with moderate to severe secondary hyperparathyroidism Nephrol. Dial. Transplant., July 1, 2008; 23(7): 2311 - 2318. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Denhaerynck, D. Manhaeve, F. Dobbels, D. Garzoni, C. Nolte, and S. De Geest PREVALENCE AND CONSEQUENCES OF NONADHERENCE TO HEMODIALYSIS REGIMENS Am. J. Crit. Care., May 1, 2007; 16(3): 222 - 235. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. R Bailie, S. J Elder, N. A Mason, Y. Asano, J. M Cruz, S. Fukuhara, A. A Lopes, D. L Mapes, D. C Mendelssohn, J. Bommer, et al. Sexual dysfunction in dialysis patients treated with antihypertensive or antidepressive medications: results from the DOPPS Nephrol. Dial. Transplant., April 1, 2007; 22(4): 1163 - 1170. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. D. Patel and M. M. Davis Falling into the Doughnut Hole: Drug Spending among Beneficiaries with End-Stage Renal Disease under Medicare Part D Plans J. Am. Soc. Nephrol., September 1, 2006; 17(9): 2546 - 2553. [Abstract] [Full Text] [PDF]
|
|